drugset / Trial / NCT06288477

Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol

NCT06288477

RandomizedParallel-groupSingle-blindTreatment

Summary

Despite the benefit of formocresol, there are toxic effects allergic reactions and local soft and hard tissue necrosis have been reported when such formaldehyde compounds were used clinically, however, the adverse effect of the clinically used of this compound are not widely reported. It has been stated that it has a side effect on the permanent successor although it results as a successful technique for the treatment of the primary teeth

Timeline

Start
2024-03-20
Primary completion
2024-05-01
Completion
2025-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Formocresol Other / unclassified
Subject Premixed bioceramic MTA Other / unclassified

Indications